Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial: A Reply

被引:0
|
作者
Melissa Pilewskie
Kimberly J. Van Zee
Monica Morrow
机构
[1] Breast Service,
[2] Department of Surgery,undefined
[3] Memorial Sloan Kettering Cancer Center,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:568 / 569
页数:1
相关论文
共 35 条
  • [1] Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial: A Reply
    Pilewskie, Melissa
    Van Zee, Kimberly J.
    Morrow, Monica
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S568 - S569
  • [2] Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial
    Daniel Rea
    Adele Francis
    Matthew Wallis
    Jeremy Thomas
    John Bartlett
    Sarah Bowden
    David Dodwell
    Lesley Fallowfield
    Claire Gaunt
    Andrew Hanby
    Valerie Jenkins
    Lucy Matthews
    Sarah Pinder
    Sarah Pirrie
    Malcolm Reed
    Margaret Wilcox
    Tracy Roberts
    Cliona Kirwan
    Cassandra Brookes
    Patricia Fairbrother
    Lucinda Billingham
    Andrew Evans
    Jennie Young
    [J]. Annals of Surgical Oncology, 2017, 24 : 566 - 567
  • [3] Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial
    Rea, Daniel
    Francis, Adele
    Wallis, Matthew
    Thomas, Jeremy
    Bartlett, John
    Bowden, Sarah
    Dodwell, David
    Fallowfield, Lesley
    Gaunt, Claire
    Hanby, Andrew
    Jenkins, Valerie
    Matthews, Lucy
    Pinder, Sarah
    Pirrie, Sarah
    Reed, Malcolm
    Wilcox, Margaret
    Roberts, Tracy
    Kirwan, Cliona
    Brookes, Cassandra
    Fairbrother, Patricia
    Billingham, Lucinda
    Evans, Andrew
    Young, Jennie
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S566 - S567
  • [4] LORIS the low risk DCIS trial: an update
    Wallis, Matthew
    [J]. BREAST CANCER RESEARCH, 2018, 20
  • [5] Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ (DCIS) Patient Population at Low-risk of Upgrade to Invasive Carcinoma?
    Pilewskie, M.
    Stempel, M.
    Rosenfeld, H.
    Eaton, A.
    Van Zee, K. J.
    Morrow, M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S25 - S26
  • [6] Women with Low-Risk DCIS Eligible for the LORIS Trial After Complete Surgical Excision: How Low Is Their Risk After Standard Therapy?
    Melissa Pilewskie
    Cristina Olcese
    Sujata Patil
    Kimberly J. Van Zee
    [J]. Annals of Surgical Oncology, 2016, 23 : 4253 - 4261
  • [7] Women with Low-Risk DCIS Eligible for the LORIS Trial After Complete Surgical Excision: How Low Is Their Risk After Standard Therapy?
    Pilewskie, Melissa
    Olcese, Cristina
    Patil, Sujata
    Van Zee, Kimberly J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (13) : 4253 - 4261
  • [8] The international collaboration of active surveillance trials for low-risk DCIS (LORIS, LORD, COMET, LORETTA).
    Kanbayashi, Chizuko
    Thompson, Alastair Mark
    Hwang, Eun-Sil Shelley
    Partridge, Ann H.
    Rea, Daniel William
    Wesseling, Jelle
    Shien, Tadahiko
    Mizutani, Tomonori
    Shibata, Taro
    Iwata, Hiroji
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Time for a low-risk DCIS trial: harnessing public and patient involvement
    Fallowfield, Lesley
    Francis, Adele
    Catt, Susan
    Mackenzie, Mairead
    Jenkins, Valerie
    [J]. LANCET ONCOLOGY, 2012, 13 (12): : 1183 - 1185
  • [10] Concordance between vacuum assisted biopsy and postoperative histology: Implications for the proposed Low Risk DCIS Trial (LORIS)
    Soumian, S.
    Verghese, E. T.
    Booth, M.
    Sharma, N.
    Chaudhri, S.
    Bradley, S.
    Umranikar, S.
    Millican-Slater, R. A.
    Hanby, A. M.
    Francis, A.
    [J]. EJSO, 2013, 39 (12): : 1337 - 1340